Asburce Olgac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Asburce Olgac has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Çiğdem Seher Kasapkara
Ankara Yildirim Beyazit University
6 shared publications - Gürsel Biberoğlu
GAZİ ÜNİVERSİTES
4 shared publications Leyla Tümer
Division of Pediatric Metabolism and Nutrition, Gazi University Hospital, Ankara, Turkey
4 shared publicationsMustafa Kılıç
4 shared publicationsSerdar Ceylaner
Intergen Genet Diag Ctr, Genet, Ankara, Turkey
4 shared publicationsÇiğdem Seher Kasapkara
Department of Pediatric Metabolism , Yıldırım Beyazıt University, Ankara City Hospital , Ankara , Turkey
4 shared publications
Latest Publications
- 29 September 2026
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 16 (5) , 243-248
Demographic Characteristics, Clinical Features, and Surgical History in Children with Mucopolysaccharidoses: A Single Center Experience
Background: Mucopolysaccharidoses (MPS) are a heterogeneous group of lysosomal storage disorders characterized by progressive glycosaminoglycan accumulation and multisystem involvement. Owing to their broad clinical spectrum, patients require lifelong multidisciplinary follow-up. This study aimed to characterize the demographic profile, clinical manifestations, and surgical history of pediatric patients with mucopolysaccharidoses followed at a tertiary referral center.Methods: This retrospective descriptive study included 10 patients with confirmed MPS. Demographic characteristics, MPS subtype, enzyme replacement therapy (ERT) status, hearing and ophthalmological findings, cardiac involvement, and surgical history were retrospectively reviewed from medical records.Results: Ten patients (6 males, 4 females) were included. The cohort comprised three patients with MPS VI, two with MPS II, and one patient each with MPS I, IVA, IIIB, IIIC, and IIID. Seven patients (70%) were receiving ERT. Cardiac involvement was identified in four patients (40%), whereas hearing impairment was documented in three patients (30%). Five patients (50%) had a history surgical intervention. Otorhinolaryngological procedures were the most common operations, followed by inguinal hernia repair, trigger finger release, cervical stabilization, and neurosurgical procedures. Airway abnormalities and cervical spine involvement were notable perioperative findings.Conclusion: This case series demonstrates the marked clinical heterogeneity of MPS and its multisystem manifestations. Despite advances in disease-specific therapy, many patients continue to require multidisciplinary follow-up because of persistent cardiac, auditory, musculoskeletal, and airway involvement. Recognition of perioperative risk factors may facilitate safer surgical management when operative interventions are required.
- 29 September 2026
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 16 (5) , 243-248
Demographic Characteristics, Clinical Features, and Surgical History in Children with Mucopolysaccharidoses: A Single Center Experience
Background: Mucopolysaccharidoses (MPS) are a heterogeneous group of lysosomal storage disorders characterized by progressive glycosaminoglycan accumulation and multisystem involvement. Owing to their broad clinical spectrum, patients require lifelong multidisciplinary follow-up. This study aimed to characterize the demographic profile, clinical manifestations, and surgical history of pediatric patients with mucopolysaccharidoses followed at a tertiary referral center.Methods: This retrospective descriptive study included 10 patients with confirmed MPS. Demographic characteristics, MPS subtype, enzyme replacement therapy (ERT) status, hearing and ophthalmological findings, cardiac involvement, and surgical history were retrospectively reviewed from medical records.Results: Ten patients (6 males, 4 females) were included. The cohort comprised three patients with MPS VI, two with MPS II, and one patient each with MPS I, IVA, IIIB, IIIC, and IIID. Seven patients (70%) were receiving ERT. Cardiac involvement was identified in four patients (40%), whereas hearing impairment was documented in three patients (30%). Five patients (50%) had a history surgical intervention. Otorhinolaryngological procedures were the most common operations, followed by inguinal hernia repair, trigger finger release, cervical stabilization, and neurosurgical procedures. Airway abnormalities and cervical spine involvement were notable perioperative findings.Conclusion: This case series demonstrates the marked clinical heterogeneity of MPS and its multisystem manifestations. Despite advances in disease-specific therapy, many patients continue to require multidisciplinary follow-up because of persistent cardiac, auditory, musculoskeletal, and airway involvement. Recognition of perioperative risk factors may facilitate safer surgical management when operative interventions are required.
- 3 September 2026
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 65 (3) , 616-619
A case of Krabbe disease presenting with hydrocephalus
Krabbe disease, or globoid cell leukodystrophy, is a rare autosomal recessive lysosomal storage disorder caused by deficiency of galactocerebrosidase (GALC) enzyme activity. While classic infantile presentation typically includes irritability, spasticity, and developmental regression, this report describes an atypical initial manifestation with acute hydrocephalus. A four-month-old female infant, born to consanguineous parents, presented with poor feeding, lethargy, hypotonia, and episodic staring. Physical examination revealed failure to thrive with normal head circumference. Neuroimaging demonstrated acute hydrocephalus and characteristic white matter abnormalities including T2 hyperintensities in the dentate nucleus and internal capsule. Cerebrospinal fluid (CSF) analysis showed significantly elevated protein levels. The diagnosis was confirmed through markedly reduced galactocerebrosidase activity (0.2 nmol/hour/mg protein; reference >0.3) and identification of a homozygous pathogenic variant in the GALC gene (c.908C>T p.Ser303Phe). This case emphasizes that acute hydrocephalus can represent an uncommon but critical presenting feature of infantile Krabbe disease. In infants with unexplained neurological deterioration and hydrocephalus, particularly with consanguineous family history, prompt metabolic evaluation including cerebrospinal fluid analysis and specific enzyme assays is essential for diagnosis. Early identification remains crucial for considering potential therapeutic interventions, including hematopoietic stem cell transplantation.
- 3 September 2026
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 65 (3) , 616-619
A case of Krabbe disease presenting with hydrocephalus
Krabbe disease, or globoid cell leukodystrophy, is a rare autosomal recessive lysosomal storage disorder caused by deficiency of galactocerebrosidase (GALC) enzyme activity. While classic infantile presentation typically includes irritability, spasticity, and developmental regression, this report describes an atypical initial manifestation with acute hydrocephalus. A four-month-old female infant, born to consanguineous parents, presented with poor feeding, lethargy, hypotonia, and episodic staring. Physical examination revealed failure to thrive with normal head circumference. Neuroimaging demonstrated acute hydrocephalus and characteristic white matter abnormalities including T2 hyperintensities in the dentate nucleus and internal capsule. Cerebrospinal fluid (CSF) analysis showed significantly elevated protein levels. The diagnosis was confirmed through markedly reduced galactocerebrosidase activity (0.2 nmol/hour/mg protein; reference >0.3) and identification of a homozygous pathogenic variant in the GALC gene (c.908C>T p.Ser303Phe). This case emphasizes that acute hydrocephalus can represent an uncommon but critical presenting feature of infantile Krabbe disease. In infants with unexplained neurological deterioration and hydrocephalus, particularly with consanguineous family history, prompt metabolic evaluation including cerebrospinal fluid analysis and specific enzyme assays is essential for diagnosis. Early identification remains crucial for considering potential therapeutic interventions, including hematopoietic stem cell transplantation.
- Open Access
- 4 March 2026
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 12 (1)
Coffin–Lowry Sendromunun Fenotipik ve Genotipik Spektrumunun Genişletilmesi: Beş Olguda Klinik, Genetik ve Dismorfik Bulgular
Amaç: Coffin–Lowry sendromu (CLS), RPS6KA3 genindeki patojenik değişikliklerin neden olduğu; değişken derecelerde entelektüel yetersizlik, ayırt edici kraniyofasiyal özellikler ve kas-iskelet sistemi anomalileri ile karakterize, nadir görülen X’e bağlı dominant bir nörogelişimsel bozukluktur. Bu çalışmada, dört aileden beş etkilenmiş bireyin (4 kadın, 1 erkek) klinik ve moleküler bulguları, kadın fenotipe odaklanılarak sunulmaktadır. Gereç ve Yöntemler: Akraba olmayan dört aileden beş etkilenmiş birey klinik olarak değerlendirildi. Genetik incelemeler; klinik ekzom dizileme, kromozomal mikrodizin analizi ile doğrulama ve segregasyon amacıyla Sanger dizilemesini içerecek şekilde gerçekleştirildi. İskelet bulgularını değerlendirmek üzere radyografik incelemeler yapıldı.Bulgular: Tüm olgularda değişen şiddette global gelişme geriliği, kraniyofasiyal dismorfik bulgular ve kas-iskelet sistemi anomalileri saptandı. Moleküler testlerde RPS6KA3 geninde daha önce bildirilmemiş bir missense varyant, iki yineleyen (rekürren) varyant ve RPS6KA3 genini de içeren bir kopya sayısı değişikliği belirlendi. Bir bireyde kalıtımın maternal kökenli olduğu gösterilirken, diğer varyantların de novo geliştiği görüldü. Radyografik değerlendirmede spondiler, metafizer veya epifizer displazi saptanmadı. Ayrıca olguların bir kısmında renal, oftalmolojik ve kardiyak anomaliler kaydedilerek CLS ile ilişkili multisistem tutulum daha da desteklendi.Sonuç: Bu olgu serisi, özellikle kadınlarda olmak üzere CLS’nin fenotipik ve genotipik spektrumunu genişletmekte ve doğru tanı için klinik ve moleküler değerlendirmenin bütünleşik kullanımının önemini vurgulamaktadır. Daha önce bildirilen ve yeni RPS6KA3 değişikliklerinin saptanması, genotip–fenotip korelasyonlarının geliştirilmesine yönelik çalışmalara katkı sağlamakta ve CLS’de klinik değişkenliğin daha sistematik biçimde araştırılması gereksiniminin altını çizmektedir.
- 4 March 2026
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 12 (1)
Open AccessCoffin–Lowry Sendromunun Fenotipik ve Genotipik Spektrumunun Genişletilmesi: Beş Olguda Klinik, Genetik ve Dismorfik Bulgular
Amaç: Coffin–Lowry sendromu (CLS), RPS6KA3 genindeki patojenik değişikliklerin neden olduğu; değişken derecelerde entelektüel yetersizlik, ayırt edici kraniyofasiyal özellikler ve kas-iskelet sistemi anomalileri ile karakterize, nadir görülen X’e bağlı dominant bir nörogelişimsel bozukluktur. Bu çalışmada, dört aileden beş etkilenmiş bireyin (4 kadın, 1 erkek) klinik ve moleküler bulguları, kadın fenotipe odaklanılarak sunulmaktadır. Gereç ve Yöntemler: Akraba olmayan dört aileden beş etkilenmiş birey klinik olarak değerlendirildi. Genetik incelemeler; klinik ekzom dizileme, kromozomal mikrodizin analizi ile doğrulama ve segregasyon amacıyla Sanger dizilemesini içerecek şekilde gerçekleştirildi. İskelet bulgularını değerlendirmek üzere radyografik incelemeler yapıldı.Bulgular: Tüm olgularda değişen şiddette global gelişme geriliği, kraniyofasiyal dismorfik bulgular ve kas-iskelet sistemi anomalileri saptandı. Moleküler testlerde RPS6KA3 geninde daha önce bildirilmemiş bir missense varyant, iki yineleyen (rekürren) varyant ve RPS6KA3 genini de içeren bir kopya sayısı değişikliği belirlendi. Bir bireyde kalıtımın maternal kökenli olduğu gösterilirken, diğer varyantların de novo geliştiği görüldü. Radyografik değerlendirmede spondiler, metafizer veya epifizer displazi saptanmadı. Ayrıca olguların bir kısmında renal, oftalmolojik ve kardiyak anomaliler kaydedilerek CLS ile ilişkili multisistem tutulum daha da desteklendi.Sonuç: Bu olgu serisi, özellikle kadınlarda olmak üzere CLS’nin fenotipik ve genotipik spektrumunu genişletmekte ve doğru tanı için klinik ve moleküler değerlendirmenin bütünleşik kullanımının önemini vurgulamaktadır. Daha önce bildirilen ve yeni RPS6KA3 değişikliklerinin saptanması, genotip–fenotip korelasyonlarının geliştirilmesine yönelik çalışmalara katkı sağlamakta ve CLS’de klinik değişkenliğin daha sistematik biçimde araştırılması gereksiniminin altını çizmektedir.
- Open Access
- 23 October 2025
- Published by Galenos Yayinevi in Inherited Metabolic Disorders and Nutrition
The Role of New-Generation Omics Technologies in Diagnosis, Monitoring, and Development of New Treatment Strategies for Inherited Metabolic Diseases
The Role of New-Generation Omics Technologies in Diagnosis, Monitoring, and Development of New Treatment Strategies for Inherited Metabolic Diseases - Inherited Metabolic Disorders and Nutrition
- 23 October 2025
- Published by Galenos Yayinevi in Inherited Metabolic Disorders and Nutrition
Open AccessThe Role of New-Generation Omics Technologies in Diagnosis, Monitoring, and Development of New Treatment Strategies for Inherited Metabolic Diseases
The Role of New-Generation Omics Technologies in Diagnosis, Monitoring, and Development of New Treatment Strategies for Inherited Metabolic Diseases - Inherited Metabolic Disorders and Nutrition
- 28 September 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (3) , 182-191
Pediatric Mitochondrial Disease: Clinical and Genetic Insights From a Single-Center Cohort
Background: Mitochondrial diseases are a heterogeneous group of inherited metabolic disorders characterized by dysfunction in oxidative phosphorylation, leading to impaired cellular energy metabolism. These disorders present with a broad clinical spectrum, often involving the nervous system, muscles, heart, and liver, making diagnosis complex. Methods: This retrospective study evaluates the clinical, laboratory, and genetic characteristics of 19 pediatric patients diagnosed with mitochondrial diseases at the pediatric metabolism clinic. Results: The most common clinical findings were hypotonia (52.6%), lactic acidosis (26.3%), and seizures (21.1%), followed by neuromotor delay (10.5%) and bilateral optic atrophy (10.5%). These findings reflect the multisystemic involvement and neurological predominance typical of mitochondrial disorders. Biochemical analyses frequently revealed abnormal metabolic profiles supportive of mitochondrial dysfunction. Conclusions: Genetic analyses identified various mitochondrial DNA and nuclear DNA mutations, underscoring the importance of comprehensive molecular diagnostics. Molecular testing improved diagnostic accuracy and facilitated more tailored patient management, including early initiation of supportive treatments and genetic counselling.
- 28 September 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (3) , 182-191
Pediatric Mitochondrial Disease: Clinical and Genetic Insights From a Single-Center Cohort
Background: Mitochondrial diseases are a heterogeneous group of inherited metabolic disorders characterized by dysfunction in oxidative phosphorylation, leading to impaired cellular energy metabolism. These disorders present with a broad clinical spectrum, often involving the nervous system, muscles, heart, and liver, making diagnosis complex. Methods: This retrospective study evaluates the clinical, laboratory, and genetic characteristics of 19 pediatric patients diagnosed with mitochondrial diseases at the pediatric metabolism clinic. Results: The most common clinical findings were hypotonia (52.6%), lactic acidosis (26.3%), and seizures (21.1%), followed by neuromotor delay (10.5%) and bilateral optic atrophy (10.5%). These findings reflect the multisystemic involvement and neurological predominance typical of mitochondrial disorders. Biochemical analyses frequently revealed abnormal metabolic profiles supportive of mitochondrial dysfunction. Conclusions: Genetic analyses identified various mitochondrial DNA and nuclear DNA mutations, underscoring the importance of comprehensive molecular diagnostics. Molecular testing improved diagnostic accuracy and facilitated more tailored patient management, including early initiation of supportive treatments and genetic counselling.
- Open Access
- 31 January 2025
- Published by Adnan Menderes University in Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
- Vol. 9 (1) , 37-48
Çocuk Sağlığı ve Hastalıkları Asistanlarının Metabolik Hastalıklar Hakkında Farkındalığı
Amaç: Kalıtsal metabolik hastalıklar, çocuk sağlığını tehdit eden önemli bir hastalık grubunu oluşturur. Çalışmamız, çocuk sağlığı ve hastalıkları asistanlarının metabolik hastalıklar hakkında farkındalığını artırmalarının kritik rolüne odaklanmaktadır. Bu hastalıkların inceliklerini anlamak, erken uyarı işaretlerini tanımak, uygun bakım sağlamak ve etkilenen çocuklar için daha iyi bir yaşam kalitesi sağlama açısından büyük önem taşır. Çalışmamız, T.C.S.B. Ankara Etlik Şehir Hastanesi Pediatri Asistanları temel alınarak gerçekleştirilmiş olup, pediatri asistanlarının metabolik hastalıklar hakkındaki farkındalığını değerlendirmeyi amaçlamıştır. Yöntem: Çalışma, 6 aylık bir süreçte online anket yöntemiyle gerçekleştirilmiştir. Katılımcılar, yaş, cinsiyet, eğitim durumu, pediatri asistanlığında geçirdikleri süre, metabolik hastalıkları kliniği deneyimi gibi demografik bilgileri sağlamış ve metabolik hastalıklarla ilgili algıları, yönetim ve görüşleri değerlendirilmiştir. Bulgular: Çalışmaya 112 katılımcı dahil olmuş, çoğunluğunu kadınlar oluşturmuştur. Katılımcıların yaş ortalaması 28.48'dir. Katılımcıların çoğu Ankara Etlik Şehir Hastanesi'nde pediatri asistanlığı yapmaktadır ve çoğunluğu yüz yüze pediatri stajı almıştır. Ayrıca, katılımcıların büyük bir kısmı meslek hayatlarının herhangi bir evresinde kalıtsal metabolik hastalık tanısı olan bir hastayı değerlendirmiş veya tartışmıştır. Asistanlık yılları ve metabolik hastalık bilgisi arasında puan bakımından istatistiksel olarak anlamlı fark saptanmıştır (p
- 31 January 2025
- Published by Adnan Menderes University in Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
- Vol. 9 (1) , 37-48
Open AccessÇocuk Sağlığı ve Hastalıkları Asistanlarının Metabolik Hastalıklar Hakkında Farkındalığı
Amaç: Kalıtsal metabolik hastalıklar, çocuk sağlığını tehdit eden önemli bir hastalık grubunu oluşturur. Çalışmamız, çocuk sağlığı ve hastalıkları asistanlarının metabolik hastalıklar hakkında farkındalığını artırmalarının kritik rolüne odaklanmaktadır. Bu hastalıkların inceliklerini anlamak, erken uyarı işaretlerini tanımak, uygun bakım sağlamak ve etkilenen çocuklar için daha iyi bir yaşam kalitesi sağlama açısından büyük önem taşır. Çalışmamız, T.C.S.B. Ankara Etlik Şehir Hastanesi Pediatri Asistanları temel alınarak gerçekleştirilmiş olup, pediatri asistanlarının metabolik hastalıklar hakkındaki farkındalığını değerlendirmeyi amaçlamıştır. Yöntem: Çalışma, 6 aylık bir süreçte online anket yöntemiyle gerçekleştirilmiştir. Katılımcılar, yaş, cinsiyet, eğitim durumu, pediatri asistanlığında geçirdikleri süre, metabolik hastalıkları kliniği deneyimi gibi demografik bilgileri sağlamış ve metabolik hastalıklarla ilgili algıları, yönetim ve görüşleri değerlendirilmiştir. Bulgular: Çalışmaya 112 katılımcı dahil olmuş, çoğunluğunu kadınlar oluşturmuştur. Katılımcıların yaş ortalaması 28.48'dir. Katılımcıların çoğu Ankara Etlik Şehir Hastanesi'nde pediatri asistanlığı yapmaktadır ve çoğunluğu yüz yüze pediatri stajı almıştır. Ayrıca, katılımcıların büyük bir kısmı meslek hayatlarının herhangi bir evresinde kalıtsal metabolik hastalık tanısı olan bir hastayı değerlendirmiş veya tartışmıştır. Asistanlık yılları ve metabolik hastalık bilgisi arasında puan bakımından istatistiksel olarak anlamlı fark saptanmıştır (p
- Open Access
- 19 September 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (6) , 784-791
Screening for creatine transporter deficiency in autism spectrum disorder: a pilot study
Objectives: Investigation of inherited metabolic disorders in autism spectrum disorder (ASD) is a matter of debate. X-linked creatine transporter deficiency is among the metabolic disorders which may present predominantly with features of ASD and intellectual disability. Here, we aimed to screen for creatine transporter deficiency in boys with ASD at a university hospital in Turkey. Methods: Random urine samples were collected from males with ASD (age 3–18 years); urine creatinine, creatine and guanidinoacetate levels were determined by liquid chromatography – tandem mass spectrometry. Demographic and clinical data were obtained via history and physical examination. The primary outcome was the diagnosis of creatine transporter deficiency (elevated urinary creatine:creatinine ratio). The diagnosis of guanidinoacetate methyltransferase deficiency and the parameters associated with the creatine metabolites were secondary outcomes. Results: Forty seven boys were enrolled, 21.3 and 19.1 % of whom had gross motor delay or paroxysmal abnormalities. 55.3 and 51.1 % patients had low urine creatine and guanidinoacetate levels, respectively, and no cases of creatine transporter deficiency or guanidinoacetate methyltransferase deficiency were identified. Age at ASD diagnosis, age at speech onset, otic or ocular dysmorphic features and psychotropic medications were weakly associated with creatine metabolites. Conclusions: We found no evidence to support routine screening of boys with ASD for creatine transporter deficiency, but the small number of participants is a limitation. Associates of urinary creatine metabolites were not considered to be clinically significant. High proportion of patients with low creatine and guanidinoacetate levels may be due to nutritional issues, and requires further study.
- 19 September 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (6) , 784-791
Open AccessScreening for creatine transporter deficiency in autism spectrum disorder: a pilot study
Objectives: Investigation of inherited metabolic disorders in autism spectrum disorder (ASD) is a matter of debate. X-linked creatine transporter deficiency is among the metabolic disorders which may present predominantly with features of ASD and intellectual disability. Here, we aimed to screen for creatine transporter deficiency in boys with ASD at a university hospital in Turkey. Methods: Random urine samples were collected from males with ASD (age 3–18 years); urine creatinine, creatine and guanidinoacetate levels were determined by liquid chromatography – tandem mass spectrometry. Demographic and clinical data were obtained via history and physical examination. The primary outcome was the diagnosis of creatine transporter deficiency (elevated urinary creatine:creatinine ratio). The diagnosis of guanidinoacetate methyltransferase deficiency and the parameters associated with the creatine metabolites were secondary outcomes. Results: Forty seven boys were enrolled, 21.3 and 19.1 % of whom had gross motor delay or paroxysmal abnormalities. 55.3 and 51.1 % patients had low urine creatine and guanidinoacetate levels, respectively, and no cases of creatine transporter deficiency or guanidinoacetate methyltransferase deficiency were identified. Age at ASD diagnosis, age at speech onset, otic or ocular dysmorphic features and psychotropic medications were weakly associated with creatine metabolites. Conclusions: We found no evidence to support routine screening of boys with ASD for creatine transporter deficiency, but the small number of participants is a limitation. Associates of urinary creatine metabolites were not considered to be clinically significant. High proportion of patients with low creatine and guanidinoacetate levels may be due to nutritional issues, and requires further study.
- 15 May 2023
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 5 (2) , 231-6
COVID-19 Infection in Patients with Gaucher Disease
Aim: Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome with a high mortality rate and has been labeled a global pandemic in March 2020. Gaucher Disease (GD) is one of the rare inherited lysosomal storage diseases (LSDs). We aimed to call attention to the frequency, susceptibility of COVID-19 infection, and the factors that prevent this infection in patients with GD as compared to other LSDs. Material and Methods: The study was conducted retrospectively between September and December 2020. Participants were divided into two groups: GD group (19 patients) and the control group (19 patients, those with other LSDs). All patients were contacted by phone to collect data about their health status, and any possible contact with Covid-19 patients. Results: Six of the GD patients (36.8%) had contacted a confirmed COVID-19 infected person but only three (15.8%) had developed a mild COVID-19 with fever and fatigue that did not require hospital admission. Four of the control group patients (21.1%) had experienced contact with a person with a confirmed COVID-19 infection. Three of the control group patients, that comprised of patients with various LSDs other than GD (15.8%) were positive on COVID-19 PCR tests and two of them had developed a mild COVID-19 infection. One of these (with Mucopolysaccharidosis type 1) had severe symptoms and required hospitalization. Conclusion: There is no consensus on the management of rare diseases such as lysosomal storage diseases during the COVID-19 pandemic. Developing plans regarding the management of COVID-19 infections in LSDs will be useful when drawing up consensus guidelines.
- 15 May 2023
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 5 (2) , 231-6
COVID-19 Infection in Patients with Gaucher Disease
Aim: Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome with a high mortality rate and has been labeled a global pandemic in March 2020. Gaucher Disease (GD) is one of the rare inherited lysosomal storage diseases (LSDs). We aimed to call attention to the frequency, susceptibility of COVID-19 infection, and the factors that prevent this infection in patients with GD as compared to other LSDs. Material and Methods: The study was conducted retrospectively between September and December 2020. Participants were divided into two groups: GD group (19 patients) and the control group (19 patients, those with other LSDs). All patients were contacted by phone to collect data about their health status, and any possible contact with Covid-19 patients. Results: Six of the GD patients (36.8%) had contacted a confirmed COVID-19 infected person but only three (15.8%) had developed a mild COVID-19 with fever and fatigue that did not require hospital admission. Four of the control group patients (21.1%) had experienced contact with a person with a confirmed COVID-19 infection. Three of the control group patients, that comprised of patients with various LSDs other than GD (15.8%) were positive on COVID-19 PCR tests and two of them had developed a mild COVID-19 infection. One of these (with Mucopolysaccharidosis type 1) had severe symptoms and required hospitalization. Conclusion: There is no consensus on the management of rare diseases such as lysosomal storage diseases during the COVID-19 pandemic. Developing plans regarding the management of COVID-19 infections in LSDs will be useful when drawing up consensus guidelines.
- Open Access
- 22 March 2023
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 17 (2) , 101-105
Clinical Characteristics of Pediatric Patients with Urea Cycle Disorders
Amaç: Üre döngüsü bozuklukları (ÜDB’leri), protein metabolizması sonucunda üretilen amonyağın hücresel atılımında yer alan enzimlerin veya taşıyıcı moleküllerinin kalıtsal eksikliklerinden kaynaklanan doğumsal metabolik hastalıklardır. Bu çalışmanın amacı, bölümümüzde takipli olup, ÜDB olan pediatrik yaş grubundaki hastaların klinik özelliklerini ve uzun dönem sonuçlarını değerlendirmektir.Gereç ve Yöntemler: Araştırmamız Eylül 2020-Mart 2021 tarihleri arasında, Dr. Sami Ulus Kadın Doğum ve Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi’nde gerçekleştirildi. ÜDB olan 16 hastada [karbamoilfosfatsentetaz I eksikliği (n=1), N-asetil glutamate sentaz eksikliği(n=1), arginino süksinat liyaz eksikliği (n=4), argininosüksinat sentetaz eksikliği (n=4), arginaz eksikliği (n=2), ornitin transkarbamilaz eksikliği (n=2), hiperamonyemi-hiperornitinemi-homositrülinüri sendromu (n=2)] klinik özellikler geriye yönelik olarak tarandı. Semptomlar yaşamın 28 günü içinde ortaya çıkmış ise “neonatal başlangıçlı ÜDB” terimi, semptomlar yenidoğan döneminden sonra başladı ise “geç başlangıçlı ÜDB” terimi kullanıldı. Bulgular: Sekiz hasta yenidoğan döneminde akut metabolik kriz ile başvurmuştu. Neonatal başlangıçlı ÜDB’lerde temel klinik fenotip sepsis benzeri bulguları içerirken, geç başlangıçlı ÜDB’lerde epilepsy ve mental retardasyon baskındı. Neonatal başlangıçlı ÜDB olan hastalarda, başlangıç döneminde hiperamonyeminin daha şiddetli olduğu gözlemlendi. Sonuç: Gelişmekte olan tedavi yöntemlerine rağmen, neonatal başlangıçlı ÜDB’lerde mortalite oranları halen yüksek olarak seyretmektedir. Neonatal başlangıçlı ÜDB’ler genellikle akut hiperamonyemi semptomları ile kendini gösterirken, nörolojik belirtiler geç başlangıçlı ÜDB’de sıklıkla başlangıç belirtisi olarak karşımıza çıkmaktadır. Hiperamonyemisi olan çocuk hastalarda ÜDB’lerden şüphelenilmeli ve tanıyı aydınlatmak için metabolik incelemeler ivedilikle yapılmalıdır. Anahtar Sözcükler: Hyperammonemia, Neonate, Urea Cycle ivedilikle yapılmalıdır.
- 22 March 2023
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 17 (2) , 101-105
Open AccessClinical Characteristics of Pediatric Patients with Urea Cycle Disorders
Amaç: Üre döngüsü bozuklukları (ÜDB’leri), protein metabolizması sonucunda üretilen amonyağın hücresel atılımında yer alan enzimlerin veya taşıyıcı moleküllerinin kalıtsal eksikliklerinden kaynaklanan doğumsal metabolik hastalıklardır. Bu çalışmanın amacı, bölümümüzde takipli olup, ÜDB olan pediatrik yaş grubundaki hastaların klinik özelliklerini ve uzun dönem sonuçlarını değerlendirmektir.Gereç ve Yöntemler: Araştırmamız Eylül 2020-Mart 2021 tarihleri arasında, Dr. Sami Ulus Kadın Doğum ve Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi’nde gerçekleştirildi. ÜDB olan 16 hastada [karbamoilfosfatsentetaz I eksikliği (n=1), N-asetil glutamate sentaz eksikliği(n=1), arginino süksinat liyaz eksikliği (n=4), argininosüksinat sentetaz eksikliği (n=4), arginaz eksikliği (n=2), ornitin transkarbamilaz eksikliği (n=2), hiperamonyemi-hiperornitinemi-homositrülinüri sendromu (n=2)] klinik özellikler geriye yönelik olarak tarandı. Semptomlar yaşamın 28 günü içinde ortaya çıkmış ise “neonatal başlangıçlı ÜDB” terimi, semptomlar yenidoğan döneminden sonra başladı ise “geç başlangıçlı ÜDB” terimi kullanıldı. Bulgular: Sekiz hasta yenidoğan döneminde akut metabolik kriz ile başvurmuştu. Neonatal başlangıçlı ÜDB’lerde temel klinik fenotip sepsis benzeri bulguları içerirken, geç başlangıçlı ÜDB’lerde epilepsy ve mental retardasyon baskındı. Neonatal başlangıçlı ÜDB olan hastalarda, başlangıç döneminde hiperamonyeminin daha şiddetli olduğu gözlemlendi. Sonuç: Gelişmekte olan tedavi yöntemlerine rağmen, neonatal başlangıçlı ÜDB’lerde mortalite oranları halen yüksek olarak seyretmektedir. Neonatal başlangıçlı ÜDB’ler genellikle akut hiperamonyemi semptomları ile kendini gösterirken, nörolojik belirtiler geç başlangıçlı ÜDB’de sıklıkla başlangıç belirtisi olarak karşımıza çıkmaktadır. Hiperamonyemisi olan çocuk hastalarda ÜDB’lerden şüphelenilmeli ve tanıyı aydınlatmak için metabolik incelemeler ivedilikle yapılmalıdır. Anahtar Sözcükler: Hyperammonemia, Neonate, Urea Cycle ivedilikle yapılmalıdır.
- 1 December 2022
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 32 (12) , 1629-1631
A Delayed Presentation of Arginase Deficiency Presenting with Status Epilepticus
Arginase 1(ARG1) deficiency is a rare disorder of the urea cycle. The presentation is usually late, leading to loss of intellectual milestones, spasticity and liver involvement. Hyperammonemic crises are rarely encountered. We herein present a case of a 16 -year immigrant girl of Syrian origin who was evaluated for acute onset of fever, vomiting, and seizures. Laboratory analyses showed slightly elevated lactate, creatine kinase, and coagulation parameters. Ammonium levels were also moderately increased. On 5th day of admission, she went into an encephalopathic state. Blood amino acid analysis showed highly elevated arginine levels. An increased level of orotic acid was found in urine organic acid analysis. Molecular genetic analysis of ARG1 gene showed a novel homozygous mutation.Although the presentation of ARG1 deficiency is usually chronic in the majority of patients, an acute crisis of encephalopathy due to hyperammonemia may occur and delayed diagnosis may lead to irreversible neurological damage.
- 1 December 2022
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 32 (12) , 1629-1631
A Delayed Presentation of Arginase Deficiency Presenting with Status Epilepticus
Arginase 1(ARG1) deficiency is a rare disorder of the urea cycle. The presentation is usually late, leading to loss of intellectual milestones, spasticity and liver involvement. Hyperammonemic crises are rarely encountered. We herein present a case of a 16 -year immigrant girl of Syrian origin who was evaluated for acute onset of fever, vomiting, and seizures. Laboratory analyses showed slightly elevated lactate, creatine kinase, and coagulation parameters. Ammonium levels were also moderately increased. On 5th day of admission, she went into an encephalopathic state. Blood amino acid analysis showed highly elevated arginine levels. An increased level of orotic acid was found in urine organic acid analysis. Molecular genetic analysis of ARG1 gene showed a novel homozygous mutation.Although the presentation of ARG1 deficiency is usually chronic in the majority of patients, an acute crisis of encephalopathy due to hyperammonemia may occur and delayed diagnosis may lead to irreversible neurological damage.